ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,535Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 223

$719K Total Retail Price of All Prescriptions

Rank: 23 out of 223

752 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 752 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 752 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 9,231 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
SIMVASTATIN 627 591 1 1
LEVOTHYROXINE SODIUM 437 364 2 2
ZOLPIDEM TARTRATE 360 335 3 8
AMLODIPINE BESYLATE 359 319 4 6
METFORMIN HCL 291 249 5 7
OMEPRAZOLE 289 252 6 3
LISINOPRIL 252 232 7 4
FUROSEMIDE 217 187 8 9
HYDROCHLOROTHIAZIDE 198 191 9 13
WARFARIN SODIUM 184 174 10 11
LOSARTAN POTASSIUM 173 164 11 14
POTASSIUM CHLORIDE 167 153 12 12
TRAMADOL HCL 167 127 12 18
MELOXICAM 157 134 14 33
HYDROCODONE-ACETAMINOPHEN 157 114 S3 14 5
FLUTICASONE PROPIONATE 154 123 16 27
GABAPENTIN 144 119 17 10
ATORVASTATIN CALCIUM 141 136 18 17
CITALOPRAM HBR 134 115 19 16
GLIMEPIRIDE 128 122 20 30
CARVEDILOL 110 91 21 23
PRAVASTATIN SODIUM 109 100 22 15
SERTRALINE HCL 108 74 23 21
METOPROLOL TARTRATE 107 93 24 25
TAMSULOSIN HCL 99 95 25 26
AZITHROMYCIN 88 73 26 44
DONEPEZIL HCL 88 88 26 36
LANTUS 87 72 28 34
IBUPROFEN 84 56 29 46
LOSARTAN-HYDROCHLOROTHIAZIDE 79 59 30 31
CLOPIDOGREL 75 75 31 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 64 32 29
ACTOS 70 70 33 95
CLONIDINE HCL 70 60 33 100
AMOX TR-POTASSIUM CLAVULANATE 67 52 35 190
PREDNISONE 67 63 35 43
FLUOXETINE HCL 65 53 37 24
ALLOPURINOL 64 62 38 28
CELEBREX 62 57 39 42
TRAZODONE HCL 62 58 39 22
NEXIUM 59 47 41 49
ATENOLOL 57 53 42 32
LANTUS SOLOSTAR 56 49 43 74
PEN NEEDLE 55 46 44 150
CRESTOR 55 49 44 37
BENAZEPRIL HCL 54 48 46 57
DIOVAN 54 53 46 54
KLOR-CON M20 52 52 48 67
ADVAIR DISKUS 52 51 48 47
RAMIPRIL 51 21 50 86
ZETIA 51 51 50 68
SYNTHROID 50 44 52 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.